This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
5 Citations 9 Q&As
2 Citations 10 Q&As
11 Q&As
Facts about Proprotein convertase subtilisin/kexin type 9.
Acts via a non-proteolytic mechanism to enhance the degradation of the hepatic LDLR through a clathrin LDLRAP1/ARH-mediated pathway. May stop the recycling of LDLR from endosomes to the cell surface or guide it to lysosomes for degradation.
Mouse | |
---|---|
Gene Name: | Pcsk9 |
Uniprot: | Q80W65 |
Entrez: | 100102 |
Belongs to: |
---|
peptidase S8 family |
EC 3.4.21; EC 3.4.21.111; FH3; FH3neural apoptosis regulated convertase 1; FHCL3; HCHOLA3; hypercholesterolemia, autosomal dominant 3; LDLCQ1; NARC1; NARC-1; NARC-1convertase subtilisin/kexin type 9 preproprotein; NARC1EC 3.4.21.-; Neural apoptosis-regulated convertase 1; PC9; PCSK9; Proprotein Convertase 9; proprotein convertase subtilisin/kexin type 9; Subtilisin/kexin-like protease PC9
Mass (kDA):
74.823 kDA
Mouse | |
---|---|
Location: | 4|4 C7 |
Sequence: | 4; |
Hepatocytes, kidney mesenchymal cells, intestinal ileum, colon epithelia and embryonic brain telencephalon neurons.
PMID: 12897189 by Maxwell K.N., et al. Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice.
PMID: 12552133 by Seidah N.G., et al. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation.
*More publications can be found for each product on its corresponding product page